Thumbnail - Request a copy

To What Extent Can Biosimilars Compete with Brand Name Biologics? A EU-5 Granulocyte-Colony Stimulating Factors Markets Analysis

Fusier, Isabelle; Cordonnier, Anne-Laure; Paubel, Pascal; Bocquet, François; Le Pen, Claude (2013), To What Extent Can Biosimilars Compete with Brand Name Biologics? A EU-5 Granulocyte-Colony Stimulating Factors Markets Analysis, Value in Health, 16, 7, p. A455. 10.1016/j.jval.2013.08.763

Type
Article accepté pour publication ou publié
Date
2013
Journal name
Value in Health
Volume
16
Number
7
Publisher
Elsevier
Pages
A455
Publication identifier
Metadata
Show full item record
Author(s)
Fusier, Isabelle

Cordonnier, Anne-Laure

Paubel, Pascal
Institut Droit et Santé [IDS - U1145]
Bocquet, François
Institut Droit et Santé [IDS - U1145]
Le Pen, Claude
Laboratoire d'Economie de Dauphine [LEDa]
Subjects / Keywords
Brand Name Biologics; Markets Analysis
JEL
I12 - Health Behavior